<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03722849</url>
  </required_header>
  <id_info>
    <org_study_id>Study 58136</org_study_id>
    <nct_id>NCT03722849</nct_id>
  </id_info>
  <brief_title>Functional Magnetic Resonance Imaging of ATP Cough in Chronic Cough Patients</brief_title>
  <official_title>A Functional Magnetic Resonance Imaging Study to Investigate ATP-sensitive Cough Neural Pathways in Patients With Chronic Cough Hypersensitivity</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Stuart Mazzone</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Imperial College London</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Queen's University, Belfast</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Monash University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Melbourne</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Persistent cough is a distressing symptom for people with respiratory disorders. Patients
      also often experience an ongoing urge-to-cough that prompts coughing, and which fails to
      resolve the sensation. Understanding how the brain controls cough and the urge-to-cough could
      lead to new cough suppressing therapies. The overall objective of this project is to use
      functional brain imaging (fMRI) to identify brain regions that are involved in the
      exaggerated urge-to-cough in humans with chronic cough. Our focus will be on the brainstem
      where information from the airways first arrives in the central nervous system.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 1, 2019</start_date>
  <completion_date type="Anticipated">July 30, 2020</completion_date>
  <primary_completion_date type="Anticipated">July 30, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>The experiment will consist of two sessions. The first session will involve questionnaires, followed by measures of sensitivity and behavioural responses to tussive (cough evoking) stimulation. The second session will involve functional brain imaging measures of responses to tussive stimulation.</intervention_model_description>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Brainstem neural activations</measure>
    <time_frame>18 months</time_frame>
    <description>fMRI will be used to determine the location and magnitude of neural responses in the brain during ATP and capsaicin inhalation. fMRI non-invasively measures Blood Oxygen Level Dependent (BOLD) signals in the brain which can be used to identify regions of the brain that increase activity associated with the inhaled stimuli. Comparisons between regional BOLD responses evoked by ATP and capsaicin (compared to saline) will allow the different neural networks involved in cough generation to be explored in healthy and chronic cough participants.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Behavioral responses</measure>
    <time_frame>18 months</time_frame>
    <description>Participant responses (cough and the urge-to-cough) evoked by ATP and capsaicin will be measured by counting audible coughs and by asking participants to rate their perception of urge-to-cough using visual analogue scales (VAS).</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Cough</condition>
  <arm_group>
    <arm_group_label>Chronic cough participant</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Twenty-five (25) Idiopathic chronic cough patients, defined as refractory to disease modifying therapies (eg anti-asthma medications), will be recruited.
Participants will attend two sessions. In the first they will inhale in a single breath a nebulized solutions of increasing doses of Adenosine Triphosphate (ATP; 0.2-300 microM) and capsaicin (0.5-125 microM) to determine their individual cough and urge-to-cough thresholds. In the second session, participants will undergo functional brain imaging (fMRI) for 1 hour while inhaling over 24 seconds randomly administered nebulized solutions of saline, or threshold doses of ATP or capsaicin.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy control participant</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Twenty-five (25) appropriately age and sex matched healthy non-smoking individuals will be recruited as the comparison group.
Participants will attend two sessions. In the first they will inhale in a single breath a nebulized solutions of increasing doses of ATP (0.2-300 microM) and capsaicin (0.5-125 microM) to determine their individual cough and urge-to-cough thresholds. In the second session, participants will undergo fMRI for 1 hour while inhaling over 24 seconds randomly administered nebulized solutions of saline, or threshold doses of ATP or capsaicin.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Adenosine Triphosphate</intervention_name>
    <description>Participants will inhale escalating concentrations of Adenosine Triphosphate (ATP) to induce cough and the urge-to-cough</description>
    <arm_group_label>Chronic cough participant</arm_group_label>
    <arm_group_label>Healthy control participant</arm_group_label>
    <other_name>ATP</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Capsaicin</intervention_name>
    <description>Participants will inhale escalating concentrations of capsaicin to induce cough and the urge-to-cough</description>
    <arm_group_label>Chronic cough participant</arm_group_label>
    <arm_group_label>Healthy control participant</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Functional Brain Imaging</intervention_name>
    <description>Participants will have scans of their brain activity using 3 Tesla (3T) brainstem restricted functional brain imaging (fMRI)</description>
    <arm_group_label>Chronic cough participant</arm_group_label>
    <arm_group_label>Healthy control participant</arm_group_label>
    <other_name>fMRI</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with physician diagnosed chronic refractory cough (cough lasting &gt;8 weeks).

          -  &gt; 18 years of age

          -  Must be cognitively impaired

        Exclusion Criteria:

          -  People with contraindications to MRI scanning (i.e. metal implants, claustrophobia).

          -  History of uncontrolled asthma or chronic respiratory disease (other than refractory
             cough).

          -  Evidence of an allergic reaction to capsaicin (chilli).

          -  Pregnant women.

          -  Smoking, current or recent history (last 6 months).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Stuart Mazzone, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Melbourne</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Stuart B Mazzone, PhD</last_name>
    <phone>+61383446457</phone>
    <email>stuart.mazzone@unimelb.edu.au</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Alice E McGovern, PhD</last_name>
    <phone>+61383443979</phone>
    <email>alice.mcgovern@unimelb.edu.au</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>The University of Melbourne</name>
      <address>
        <city>Parkville</city>
        <state>Victoria</state>
        <zip>3010</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stuart B Mazzone, PhD</last_name>
      <phone>+61383446457</phone>
      <email>stuart.mazzone@unimelb.edu.au</email>
    </contact>
  </location>
  <location_countries>
    <country>Australia</country>
  </location_countries>
  <reference>
    <citation>Chung KF, Pavord ID. Prevalence, pathogenesis, and causes of chronic cough. Lancet. 2008 Apr 19;371(9621):1364-74. doi: 10.1016/S0140-6736(08)60595-4. Review.</citation>
    <PMID>18424325</PMID>
  </reference>
  <reference>
    <citation>Morice AH, Jakes AD, Faruqi S, Birring SS, McGarvey L, Canning B, Smith JA, Parker SM, Chung KF, Lai K, Pavord ID, van den Berg J, Song WJ, Millqvist E, Farrell MJ, Mazzone SB, Dicpinigaitis P; Chronic Cough Registry. A worldwide survey of chronic cough: a manifestation of enhanced somatosensory response. Eur Respir J. 2014 Nov;44(5):1149-55. doi: 10.1183/09031936.00217813. Epub 2014 Sep 3.</citation>
    <PMID>25186267</PMID>
  </reference>
  <reference>
    <citation>Chung KF, McGarvey L, Mazzone SB. Chronic cough as a neuropathic disorder. Lancet Respir Med. 2013 Jul;1(5):414-22. doi: 10.1016/S2213-2600(13)70043-2. Epub 2013 May 3. Review.</citation>
    <PMID>24429206</PMID>
  </reference>
  <reference>
    <citation>Mazzone SB, McLennan L, McGovern AE, Egan GF, Farrell MJ. Representation of capsaicin-evoked urge-to-cough in the human brain using functional magnetic resonance imaging. Am J Respir Crit Care Med. 2007 Aug 15;176(4):327-32. Epub 2007 Jun 15.</citation>
    <PMID>17575093</PMID>
  </reference>
  <reference>
    <citation>Ando A, Smallwood D, McMahon M, Irving L, Mazzone SB, Farrell MJ. Neural correlates of cough hypersensitivity in humans: evidence for central sensitisation and dysfunctional inhibitory control. Thorax. 2016 Apr;71(4):323-9. doi: 10.1136/thoraxjnl-2015-207425. Epub 2016 Feb 9.</citation>
    <PMID>26860344</PMID>
  </reference>
  <reference>
    <citation>Abdulqawi R, Dockry R, Holt K, Layton G, McCarthy BG, Ford AP, Smith JA. P2X3 receptor antagonist (AF-219) in refractory chronic cough: a randomised, double-blind, placebo-controlled phase 2 study. Lancet. 2015 Mar 28;385(9974):1198-205. doi: 10.1016/S0140-6736(14)61255-1. Epub 2014 Nov 25.</citation>
    <PMID>25467586</PMID>
  </reference>
  <verification_date>October 2019</verification_date>
  <study_first_submitted>October 24, 2018</study_first_submitted>
  <study_first_submitted_qc>October 25, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">October 29, 2018</study_first_posted>
  <last_update_submitted>October 3, 2019</last_update_submitted>
  <last_update_submitted_qc>October 3, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">October 7, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>University of Melbourne</investigator_affiliation>
    <investigator_full_name>Stuart Mazzone</investigator_full_name>
    <investigator_title>Associate Professor of Neuroscience</investigator_title>
  </responsible_party>
  <keyword>functional brain imaging</keyword>
  <keyword>ATP</keyword>
  <keyword>Capsaicin</keyword>
  <keyword>Refractory cough</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cough</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Adenosine</mesh_term>
    <mesh_term>Capsaicin</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>IPD will not be shared</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

